Login
$PSNL
$15.88 +$0.03 (0.19%) Close

$PSNL 3 SEC Filings

Filed On Filing
23 Dec 2024 Form 3: Merck & Co., Inc., 10% owner and 1 other

Holds 14,044,943 shares of Common Stock, $0.0001 par value per share

03 Jul 2024 Form 3: Lefkofsky Eric P, 10% owner

Holds 150,000 shares of Common Stock

05 Dec 2023 Form 3: Tempus Labs, Inc., 10% owner
14 Jun 2023 Form 3: Widder Kenneth J, Director

No securities owned

05 Jan 2023 Form 3: Hall Christopher M, President

Holds 225,000 shares of Common Stock

04 Aug 2022 Form 3: Shoff Lonnie, Director

No securities owned

08 Mar 2022 Form 3: Moore Stephen Michael, General Counsel

Holds 45,639 shares of Common Stock

01 Mar 2022 Form 3: Bloom Olivia Kyusuk, Director

No securities owned

08 Mar 2021 Form 3: Myers Woodrow A Jr, Director

No securities owned

03 Jun 2020 Form 3: Lightspeed Venture Partners Select IV, L.p., Affiliate of 10% Owner and 3 others

Holds 77,797 shares of Common Stock

16 Sep 2019 Form 3: Eastham Karin, Director

No securities owned

19 Jun 2019 Form 3: Lightspeed Venture Partners Viii Lp, 10% owner and 9 others
19 Jun 2019 Form 3: Tachibana Aaron, Chief Financial Officer
19 Jun 2019 Form 3: Balthrop Patrick J, Director

Holds 13,541 shares of Common Stock

19 Jun 2019 Form 3: Chen Richard, Chief Scientific Officer

Holds 25,000 shares of Common Stock

19 Jun 2019 Form 3: Musil Clinton, Chief Business Officer
19 Jun 2019 Form 3: Bowman A Blaine, Director
19 Jun 2019 Form 3: Colowick Alan, Director
19 Jun 2019 Form 3: Ludlum Ken, Director

Holds 45,833 shares of Common Stock

19 Jun 2019 Form 3: MacQuitty Jonathan, Director

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support